Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma

NCT00022945 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Mantle Cell Lymphoma

Interventions

DRUG: Iodine-131 Anti-B1 Antibody
DRUG: Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP)

Sponsor

Corixa Corporation